Tizoxanide-d4
Based on 1 Customer Validation
Tizoxanide-d4 is the deuterium labeled Tizoxanide. Tizoxanide is the active metabolite of Nitazoxanide, which is a thiazolide anti-infective compound against anaerobic bacteria, protozoa, and a range of viruses. Tizoxanide has anti-HIV-1 activities.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 98.12%
- CAS No.: 1246817-56-0
- Formule: C10H3D4N3O4S
- Masse moléculaire:269.27
-
Stockage:
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-118020A
Loliolide -
HY-19727A
FOY 251 -
HY-W069721
N-Acetylsulfanilamide -
HY-N2341S
Palmitelaidic acid-d13 -
HY-B0462S
Azelastine-13C,d3 hydrochloride -
HY-19727AR
FOY 251 (Standard) -
HY-W069721R
N-Acetylsulfanilamide (Standard) -
HY-B0318S1
Metronidazole-d4 -
HY-165145
Carbazomycin C -
HY-B0335S
Tolfenamic acid-d4 -
HY-B0621S1
Triclabendazole-13C,d3
Activité biologique
Description
In Vitro
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Application
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
CAS No. 1246817-56-0
-
Unlabeled CAS 173903-47-4
-
Appearance Solid
-
Masse moléculaire 269.27
-
Formule C10H3D4N3O4S
-
Color White to off-white
-
SMILES
O=[N+]([O-])C1=CN=C(S1)NC(C2=C(C([2H])=C([2H])C([2H])=C2[2H])O)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Solvant et solubilité
In Vitro:
DMSO : 25 mg/mL (92.84 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Ethanol : 1 mg/mL (3.71 mM; ultrasonic and warming and heat to 60°C)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (274 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
[2]. Korba BE, et al. Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication. Antiviral Res. 2008 Jan;77(1):56-63. [Content Brief]
[3]. Ashton LV, et al. In Vitro Susceptibility of Canine Influenza A (H3N8) Virus to Nitazoxanide and Tizoxanide. Vet Med Int. 2010 Aug 12;2010. pii: 891010. [Content Brief]
[4]. Korba BE, et al. Potential for hepatitis C virus resistance to nitazoxanide or tizoxanide. Antimicrob Agents Chemother. 2008 Nov;52(11):4069-71. [Content Brief]
[5]. Trabattoni D, et al. Thiazolides Elicit Anti-Viral Innate Immunity and Reduce HIV Replication. Sci Rep. 2016 Jun 2;6:27148. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| Ethanol / DMSO | 1 mM | 3.7137 mL | 18.5687 mL | 37.1374 mL | 92.8436 mL |
| DMSO | 5 mM | 0.7427 mL | 3.7137 mL | 7.4275 mL | 18.5687 mL |
| 10 mM | 0.3714 mL | 1.8569 mL | 3.7137 mL | 9.2844 mL | |
| 15 mM | 0.2476 mL | 1.2379 mL | 2.4758 mL | 6.1896 mL | |
| 20 mM | 0.1857 mL | 0.9284 mL | 1.8569 mL | 4.6422 mL | |
| 25 mM | 0.1485 mL | 0.7427 mL | 1.4855 mL | 3.7137 mL | |
| 30 mM | 0.1238 mL | 0.6190 mL | 1.2379 mL | 3.0948 mL | |
| 40 mM | 0.0928 mL | 0.4642 mL | 0.9284 mL | 2.3211 mL | |
| 50 mM | 0.0743 mL | 0.3714 mL | 0.7427 mL | 1.8569 mL | |
| 60 mM | 0.0619 mL | 0.3095 mL | 0.6190 mL | 1.5474 mL | |
| 80 mM | 0.0464 mL | 0.2321 mL | 0.4642 mL | 1.1605 mL |
Tizoxanide-d4 Related Classifications
HY-12687S Related Classifications
Powered by Bioz